Biblio
A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patients. Blood Adv. 2020;4(4):644-654.
. Adult T-cell lymphoma/leukemia presenting as isolated central nervous system T-cell lymphoma. Case Rep Hematol. 2014;2014:917369.
. A CIBERSORTx-based immune-cell scoring system could independently predict prognosis of myelodysplastic syndrome patients. Blood Adv. 2021.
Clinical and Prognostic Implications of Roundabout 4 (Robo4) in Adult Patients with Acute Myeloid Leukemia. PLoS One. 2015;10(3):e0119831.
The expression levels of long non-coding RNA KIAA0125 are associated with distinct clinical and biological features in myelodysplastic syndromes. Br J Haematol. 2020.
. Hepatitis B reactivation during treatment of tyrosine kinase inhibitors-Experience in 142 adult patients with chronic myeloid leukemia. Leuk Res. 2019;81:95-97.
. Hepatitis B Surface Antigen Positivity is An Independent Unfavorable Prognostic Factor in Diffuse Large B-cell Lymphoma in The Rituximab Era. Oncologist. 2020.
. High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in Taiwan. PLoS One. 2015;10(6):e0128410.
High Risk of Hepatitis B Reactivation among Patients with Acute Myeloid Leukemia. PLoS One. 2015;10(5):e0126037.
. Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes. Blood Adv. 2024.
. Non-del(5q) myelodysplastic syndromes-associated loci detected by SNP-array genome-wide association meta-analysis. Blood Adv. 2019;3(22):3579-3589.
The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression. Haematologica. 2014.
Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults. BMC Cancer. 2015;15(1):344.
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia. Oncotarget. 2016.